Dec 2, 2012
By:
Rich Whitworth
The EMA brought together European and US expert representatives from regulatory authorities, academia, industry and a health-technology-assessment agency on Nov. 18, 2011 to discuss the use and importance of subgroup analysis in the assessment of clinical trials.
|
Feb 9, 2012
By:
Rich Whitworth
Following a packaging error affecting birth-control pills, Pfizer has issued a one-million pack recall and warned women in the US who have been taking the medication during the last several months to consult with their physicians.
|
Feb 1, 2012
By:
Rich Whitworth
"The patent expiry of several major blockbuster drugs worth $150 billion between 2010 and 2017 will fuel the growth of the global generic pharmaceuticals market," so says a press release announcing new analysis from Frost & Sullivan.
|
Jan 26, 2012
By:
Rich Whitworth
The EMA has released a concept paper for a guideline on pharmacogenomic methodologies in the evaluation of authorized medicines to address the fact that genetic differences can cause variability in drug therapy efficacy and safety.
|
Jan 25, 2012
By:
Rich Whitworth
The FDA has approved a safety label change for Biogen and Elan?s multiple sclerosis drug Tysabri identified a diagnostic test that can help identify patients at risk of developing a serious brain infection, which has been associated with the drug.
|
Jan 20, 2012
By:
Rich Whitworth
Constellation Pharmaceuticals announced that it has entered into a broad collaboration with Genentech, a member of the Roche group, to discover and develop innovative treatments based on epigenetics, which focuses on the identification of small molecule inhibitors of protein activity.
|
Jan 12, 2012
By:
Rich Whitworth
Novartis Consumer Health has announced a voluntary recall of all lots of select, bottle-packaged configurations of Excedrin, NoDoz, Bufferin and Gas-X Prevention. The recall follows consumer complaints of chipped or broken pills and inconsistent bottle packaging line clearance practices that could lead to stray tablets, capsules or caplets from other Novartis products.
|
|
Industry experts discuss formulation and technical challenges in multilayer tablet manufacture.
Jan 2, 2012
By:
Rich Whitworth, Stephanie Sutton
Industry experts discuss formulation and technical challenges in multilayer tablet manufacture.
|
Jan 1, 2012
By:
Rich Whitworth
Firstly, Happy New Year! Please help yourself to a slice of cake.
|
|
